Today's N&O published an AP article that reports that the FDA is considering approving the use of 3 psychiatric drugs for kids, currently approved for adult usage. Here is an excerpt:
The Food and Drug Administration is reviewing drugs from AstraZeneca PLC, Eli Lilly & Co. and Pfizer Inc. for use in patients between the ages of 10 and 17. The drugs - already approved to treat schizophrenia and bipolar mania in adults - had combined sales of more than $7.4 billion last year, according to IMS Health.
With only two anti-psychotic drugs currently approved for younger patients, a positive decision for the three drugs would significantly increase competition in the space - and expand sales of products that already are big sellers.
Read the entire article here.